Literature DB >> 1965008

Gamma-aminobutyric acid (GABAA) receptor-function in a rat model of hepatic encephalopathy.

B L Baker1, A L Morrow, J Vergalla, S M Paul, E A Jones.   

Abstract

The functional activity of the gamma-aminobutyric acid (GABAA) receptor-chloride ionophore complex was studied in rats with hepatic encephalopathy (HE) secondary to thioacetamide-induced fulminant hepatic failure (FHF). Muscimol stimulation and benzodiazepine potentiation of GABA receptor-mediated 36Cl- uptake into cerebral cortical synaptoneurosomes was compared in HE and control rats. [3H]Flumazenil binding assays were conducted to determine whether the levels of endogenous benzodiazepine-like ligands in extracts of cortex were increased with stages of encephalopathy in this animal model of HE. In both control and HE rats maximal uptake of 36Cl- via the GABAA receptor complex occurred at muscimol concentrations of 30 microM. Potentiation of muscimol-stimulated 36Cl- uptake into synaptoneurosomes by diazepam (5 microM) was equivalent in both groups. Aqueous extracts of proteolytically digested homogenates of cerebral cortices prepared from control and HE rats were effective in stimulating 36Cl- uptake into synaptoneurosomes. Alkaline organic extracts of proteolytically digested homogenates of cerebral cortices from HE rats were more effective than corresponding extracts from controls at inhibiting the binding of [3H]flumazenil. Inhibition of [3H] fumazenil binding by organic extracts derived from the cerebral cortices of HE rats did not increase with progression of encephalopathy. The results show that muscimol-stimulated 36Cl- uptake into synaptoneurosomes and, consequently, GABAA receptor-mediated chloride channel function are not significantly altered in the model of HE studied and are consistent with the hypothesis that HE results in an increased availability of one or more endogenous ligands which can augment GABA receptor-gated chloride conductance.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1965008     DOI: 10.1007/bf00997072

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  22 in total

1.  Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure.

Authors:  M L Bassett; K D Mullen; P Skolnick; E A Jones
Journal:  Gastroenterology       Date:  1987-11       Impact factor: 22.682

2.  Differential responsiveness of cerebellar Purkinje neurons to GABA and benzodiazepine receptor ligands in an animal model of hepatic encephalopathy.

Authors:  A S Basile; S H Gammal; K D Mullen; E A Jones; P Skolnick
Journal:  J Neurosci       Date:  1988-07       Impact factor: 6.167

3.  Hepatic encephalopathy. Application of visual evoked responses to test hypotheses of its pathogenesis in rats.

Authors:  D B Jones; K D Mullen; M Roessle; T Maynard; E A Jones
Journal:  J Hepatol       Date:  1987-02       Impact factor: 25.083

4.  Synaptic membrane complex carbohydrates in experimental hepatic encephalopathy.

Authors:  M Rössle; F P Winstanley; K Haag; K D Mullen; E A Jones
Journal:  Metab Brain Dis       Date:  1990-09       Impact factor: 3.584

Review 5.  NIH conference. The gamma-aminobutyric acid A (GABAA) receptor complex and hepatic encephalopathy. Some recent advances.

Authors:  E A Jones; P Skolnick; S H Gammal; A S Basile; K D Mullen
Journal:  Ann Intern Med       Date:  1989-04-01       Impact factor: 25.391

6.  The GABAA receptor complex in hepatic encephalopathy. Autoradiographic evidence for the presence of elevated levels of a benzodiazepine receptor ligand.

Authors:  A S Basile; N L Ostrowski; S H Gammal; E A Jones; P Skolnick
Journal:  Neuropsychopharmacology       Date:  1990-02       Impact factor: 7.853

7.  GABAA receptor complex in an experimental model of hepatic encephalopathy: evidence for elevated levels of an endogenous benzodiazepine receptor ligand.

Authors:  A S Basile; S H Gammal; E A Jones; P Skolnick
Journal:  J Neurochem       Date:  1989-10       Impact factor: 5.372

8.  Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist.

Authors:  M Baraldi; M L Zeneroli; E Ventura; A Penne; G Pinelli; P Ricci; M Santi
Journal:  Clin Sci (Lond)       Date:  1984-08       Impact factor: 6.124

9.  Increased brain uptake of gamma-aminobutyric acid in a rabbit model of hepatic encephalopathy.

Authors:  M L Bassett; K D Mullen; B Scholz; J D Fenstermacher; E A Jones
Journal:  Gastroenterology       Date:  1990-03       Impact factor: 22.682

10.  Presence and measurement of imidazoleacetic acid, a gamma-aminobutyric acid agonist, in rat brain and human cerebrospinal fluid.

Authors:  J K Khandelwal; G D Prell; A M Morrishow; J P Green
Journal:  J Neurochem       Date:  1989-04       Impact factor: 5.372

View more
  2 in total

1.  Role of Magnetic Resonance in Understanding the Pathogenesis of Hepatic Encephalopathy.

Authors:  A Huda; R K Gupta; N Rajakumar; M A Thomas
Journal:  Magn Reson Insights       Date:  2008

2.  Transplanted neuroblasts differentiate appropriately into projection neurons with correct neurotransmitter and receptor phenotype in neocortex undergoing targeted projection neuron degeneration.

Authors:  J J Shin; R A Fricker-Gates; F A Perez; B R Leavitt; D Zurakowski; J D Macklis
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.